FENNEC PHARMACEUTICALS INC. Research and Development Expense
FENNEC PHARMACEUTICALS INC. (FENC) reported Research and Development Expense of $118.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- FENNEC PHARMACEUTICALS INC. research and development expense for the quarter ending 2026-06-30 was $118.00K, a 10.28% increase year-over-year.
- FENNEC PHARMACEUTICALS INC. research and development expense for the quarter ending 2026-03-31 was $49.00K, a 47.87% decline year-over-year.
- FENNEC PHARMACEUTICALS INC. research and development expense for the quarter ending 2025-12-31 was $20.00K, a 60.00% decline year-over-year.
- FENNEC PHARMACEUTICALS INC. research and development expense for the quarter ending 2025-09-30 was $29.00K, a 70.10% decline year-over-year.
- FENNEC PHARMACEUTICALS INC. research and development expense for fiscal 2025 was $250.00K, a 18.57% decline from fiscal 2024.
- FENNEC PHARMACEUTICALS INC. research and development expense for fiscal 2024 was $307.00K, a 448.21% increase from fiscal 2023.
- FENNEC PHARMACEUTICALS INC. research and development expense for fiscal 2023 was $56.00K, a 98.41% decline from fiscal 2022.
- FENNEC PHARMACEUTICALS INC. research and development expense for fiscal 2022 was $3.53M, a 29.11% decline from fiscal 2021.
| Period end | Research and Development Expense 1 month | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month | Research and Development Expense 196 month | Research and Development Expense 208 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $118.00K 10-Q · filed 2026-08-13 | $167.00K 10-Q · filed 2026-08-13 | $187.00K derived: sum of 3 quarters · filed 2026-08-13 | $216.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $49.00K 10-Q · filed 2026-05-14 | $69.00K derived: sum of 2 quarters · filed 2026-05-14 | $98.00K derived: sum of 3 quarters · filed 2026-05-14 | $205.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $49.00K derived: sum of 2 quarters · filed 2026-03-27 | $156.00K derived: sum of 3 quarters · filed 2026-08-13 | $250.00K 10-K · filed 2026-03-27 | |||
| 2025-09-30 | $29.00K 10-Q · filed 2025-11-13 | $136.00K derived: sum of 2 quarters · filed 2026-08-13 | $230.00K 10-Q · filed 2025-11-13 | $280.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $107.00K 10-Q · filed 2026-08-13 | $201.00K 10-Q · filed 2026-08-13 | $251.00K derived: sum of 3 quarters · filed 2026-08-13 | $348.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $94.00K 10-Q · filed 2026-05-14 | $144.00K derived: sum of 2 quarters · filed 2026-05-14 | $241.00K derived: sum of 3 quarters · filed 2026-05-14 | $398.00K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $147.00K derived: sum of 2 quarters · filed 2026-03-27 | $304.00K derived: sum of 3 quarters · filed 2026-03-27 | $307.00K 10-K · filed 2026-03-27 | |||
| 2024-09-30 | $97.00K 10-Q · filed 2025-11-13 | $254.00K derived: sum of 2 quarters · filed 2025-11-13 | $257.00K 10-Q · filed 2025-11-13 | $289.00K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $157.00K 10-Q · filed 2025-08-14 | $160.00K 10-Q · filed 2025-08-14 | $192.00K derived: sum of 3 quarters · filed 2025-08-14 | $204.00K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $3.00K 10-Q · filed 2025-05-14 | $35.00K derived: sum of 2 quarters · filed 2025-05-14 | $47.00K derived: sum of 3 quarters · filed 2025-05-14 | $55.00K derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $44.00K derived: sum of 2 quarters · filed 2025-03-26 | $52.00K derived: sum of 3 quarters · filed 2025-03-26 | $56.00K 10-K · filed 2025-03-26 | |||
| 2023-09-30 | $12.00K 10-Q · filed 2024-11-08 | $20.00K derived: sum of 2 quarters · filed 2024-11-08 | $24.00K 10-Q · filed 2024-11-08 | $141.00K derived: sum of 4 quarters · filed 2024-11-08 | |||
| 2023-06-30 | $8.00K 10-Q · filed 2024-08-13 | $12.00K 10-Q · filed 2024-08-13 | $129.00K derived: sum of 3 quarters · filed 2024-08-13 | $975.00K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $4.00K 10-Q · filed 2024-05-14 | $121.00K derived: sum of 2 quarters · filed 2024-05-14 | $967.00K derived: sum of 3 quarters · filed 2024-05-14 | $2.10M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $963.00K derived: sum of 2 quarters · filed 2024-03-29 | $2.09M derived: sum of 3 quarters · filed 2024-03-29 | $3.53M 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $846.00K 10-Q · filed 2023-11-09 | $1.98M derived: sum of 2 quarters · filed 2023-11-09 | $3.41M 10-Q · filed 2023-11-09 | $3.94M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $1.13M 10-Q · filed 2023-08-07 | $2.57M 10-Q · filed 2023-08-07 | $3.09M derived: sum of 3 quarters · filed 2023-08-07 | $4.33M derived: sum of 4 quarters · filed 2023-08-07 | |||
| 2022-03-31 | $1.44M 10-Q · filed 2023-05-12 | $1.96M derived: sum of 2 quarters · filed 2023-05-12 | $3.20M derived: sum of 3 quarters · filed 2023-05-12 | $4.00M derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $523.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $1.76M derived: sum of 2 quarters · filed 2023-03-29 | $2.56M derived: sum of 3 quarters · filed 2023-03-29 | $4.98M 10-K · filed 2023-03-29 | |||
| 2021-09-30 | $1.24M 10-Q · filed 2022-11-14 | $2.04M derived: sum of 2 quarters · filed 2022-11-14 | $4.46M 10-Q · filed 2022-11-14 | $5.68M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $800.00K 10-Q · filed 2022-08-12 | $3.22M 10-Q · filed 2022-08-12 | $4.44M derived: sum of 3 quarters · filed 2022-08-12 | $5.81M derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | $2.42M 10-Q · filed 2022-05-12 | $3.64M derived: sum of 2 quarters · filed 2022-05-12 | $5.01M derived: sum of 3 quarters · filed 2022-05-12 | $6.13M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $2.59M derived: sum of 2 quarters · filed 2022-02-28 | $3.71M derived: sum of 3 quarters · filed 2022-02-28 | $5.11M 10-K · filed 2022-02-28 | |||
| 2020-09-30 | $1.37M 10-Q · filed 2021-11-10 | $2.49M derived: sum of 2 quarters · filed 2021-11-10 | $3.88M 10-Q · filed 2021-11-10 | $5.05M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $1.12M 10-Q · filed 2021-08-10 | $2.51M 10-Q · filed 2021-08-10 | $3.69M derived: sum of 3 quarters · filed 2021-08-10 | $4.48M derived: sum of 4 quarters · filed 2021-08-10 | |||
| 2020-03-31 | $1.39M 10-Q · filed 2021-05-13 | $2.56M derived: sum of 2 quarters · filed 2021-05-13 | $3.36M derived: sum of 3 quarters · filed 2021-05-13 | $5.33M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $1.97M derived: sum of 2 quarters · filed 2021-03-30 | $3.94M derived: sum of 3 quarters · filed 2021-03-30 | $5.61M 10-K · filed 2021-03-30 | |||
| 2019-09-30 | $795.00K 10-Q · filed 2020-11-16 | $2.76M derived: sum of 2 quarters · filed 2020-11-16 | $4.43M 10-Q · filed 2020-11-16 | $6.16M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | $1.97M 10-Q · filed 2020-08-05 | $3.64M 10-Q · filed 2020-08-05 | $5.36M derived: sum of 3 quarters · filed 2020-08-05 | $7.16M derived: sum of 4 quarters · filed 2020-08-05 | |||
| 2019-03-31 | $1.67M 10-Q · filed 2020-05-14 | $3.39M derived: sum of 2 quarters · filed 2020-05-14 | $5.19M derived: sum of 3 quarters · filed 2020-05-14 | $5.99M derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $3.52M derived: sum of 2 quarters · filed 2020-02-14 | $4.32M derived: sum of 3 quarters · filed 2020-02-14 | $5.01M 10-K · filed 2020-02-14 | |||
| 2018-09-30 | $1.80M 10-Q · filed 2019-11-12 | $2.60M derived: sum of 2 quarters · filed 2019-11-12 | $3.29M 10-Q · filed 2019-11-12 | $4.17M derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | $798.00K 10-Q · filed 2019-08-09 | $1.49M 10-Q · filed 2019-08-09 | $2.37M derived: sum of 3 quarters · filed 2019-08-09 | $2.87M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | $689.00K 10-Q · filed 2019-05-10 | $1.57M derived: sum of 2 quarters · filed 2019-05-10 | $2.07M derived: sum of 3 quarters · filed 2019-05-10 | $2.40M derived: sum of 4 quarters · filed 2019-05-10 | |||
| 2017-12-31 | $886.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $1.38M derived: sum of 2 quarters · filed 2019-03-15 | $1.71M derived: sum of 3 quarters · filed 2019-03-15 | $1.94M 10-K · filed 2019-03-15 | |||
| 2017-09-30 | $492.00K 10-Q · filed 2018-11-13 | $825.00K derived: sum of 2 quarters · filed 2018-11-13 | $1.05M 10-Q · filed 2018-11-13 | $1.22M derived: sum of 4 quarters · filed 2018-11-13 | |||
| 2017-06-30 | $333.00K 10-Q · filed 2018-08-13 | $558.00K 10-Q · filed 2018-08-13 | $732.00K derived: sum of 3 quarters · filed 2018-08-13 | $844.00K derived: sum of 4 quarters · filed 2018-08-13 | |||
| 2017-03-31 | $225.00K 10-Q · filed 2018-05-14 | $399.00K derived: sum of 2 quarters · filed 2018-05-14 | $511.00K derived: sum of 3 quarters · filed 2018-05-14 | $650.00K derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $286.00K derived: sum of 2 quarters · filed 2018-03-28 | $425.00K derived: sum of 3 quarters · filed 2018-03-28 | $472.00K 10-K · filed 2018-03-28 | |||
| 2016-09-30 | $112.00K 10-Q · filed 2017-11-13 | $251.00K derived: sum of 2 quarters · filed 2017-11-13 | $298.00K 10-Q · filed 2017-11-13 | $369.00K derived: sum of 4 quarters · filed 2017-11-13 | |||
| 2016-06-30 | $139.00K 10-Q · filed 2017-08-14 | $186.00K 10-Q · filed 2017-08-14 | $257.00K derived: sum of 3 quarters · filed 2017-08-14 | $345.00K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | $47.00K 10-Q · filed 2017-05-12 | $118.00K derived: sum of 2 quarters · filed 2017-05-12 | $206.00K derived: sum of 3 quarters · filed 2017-05-12 | $260.00K derived: sum of 4 quarters · filed 2017-05-12 | |||
| 2015-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $159.00K derived: sum of 2 quarters · filed 2017-03-29 | $213.00K derived: sum of 3 quarters · filed 2017-03-29 | $256.00K 10-K · filed 2017-03-29 | |||
| 2015-09-30 | $88.00K 10-Q · filed 2016-11-14 | $142.00K derived: sum of 2 quarters · filed 2016-11-14 | $185.00K 10-Q · filed 2016-11-14 | $350.00K derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | $54.00K 10-Q · filed 2016-08-12 | $97.00K 10-Q · filed 2016-08-12 | $262.00K derived: sum of 3 quarters · filed 2016-08-12 | $350.00K derived: sum of 4 quarters · filed 2016-08-12 | |||
| 2015-03-31 | $43.00K 10-Q · filed 2016-05-12 | $208.00K derived: sum of 2 quarters · filed 2016-05-12 | $296.00K derived: sum of 3 quarters · filed 2016-05-12 | $368.00K derived: sum of 4 quarters · filed 2016-05-12 | |||
| 2014-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $253.00K derived: sum of 2 quarters · filed 2016-03-28 | $325.00K derived: sum of 3 quarters · filed 2016-03-28 | $357.00K 10-K · filed 2016-03-28 | |||
| 2014-09-30 | $88.00K 10-Q · filed 2015-11-12 | $160.00K derived: sum of 2 quarters · filed 2015-11-12 | $192.00K 10-Q · filed 2015-11-12 | ||||
| 2014-06-30 | $72.00K 10-Q · filed 2015-08-11 | $104.00K 10-Q · filed 2015-08-11 | |||||
| 2013-12-31 | $579.00K 10-K · filed 2014-03-31 | $69.75M 10-K · filed 2014-03-31 | |||||
| 2012-12-31 | $2.08M 10-K · filed 2014-03-31 | $69.17M 10-K · filed 2013-04-01 | |||||
| 2011-12-31 | $1.49M 10-K · filed 2013-04-01 | ||||||
| 2003-12-19 | $1.04M 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |